Protalix BioTherapeutics (PLX) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28% |
| Dec 31, 2025 | -94.86% |
| Sep 30, 2025 | -23.74% |
| Jun 30, 2025 | -8.03% |
| Sep 30, 2024 | 17.14% |
| Jun 30, 2024 | -14.00% |
| Mar 31, 2024 | 15.13% |
| Dec 31, 2023 | 15.81% |
| Sep 30, 2023 | -57.65% |
| Jun 30, 2023 | 45.85% |
| Mar 31, 2023 | 93.07% |
| Dec 31, 2022 | 59.62% |
| Sep 30, 2022 | -14.19% |
| Jun 30, 2022 | -26.03% |
| Mar 31, 2022 | -56.68% |
| Dec 31, 2021 | 266.33% |
| Sep 30, 2021 | -68.59% |
| Jun 30, 2021 | 70.86% |
| Mar 31, 2021 | 4,448.17% |
| Dec 31, 2020 | -96.78% |
| Sep 30, 2020 | 179.43% |
| Jun 30, 2020 | -65.81% |
| Mar 31, 2020 | -20.38% |
| Dec 31, 2019 | -17.02% |
| Sep 30, 2019 | -14.56% |
| Jun 30, 2019 | -17.35% |
| Mar 31, 2019 | -19.69% |
| Dec 31, 2018 | -9.70% |
| Sep 30, 2018 | 47.80% |
| Jun 30, 2018 | -31.44% |
| Mar 31, 2018 | -19.24% |
| Dec 31, 2017 | 52.81% |
| Sep 30, 2017 | -3.04% |
| Jun 30, 2017 | -28.08% |
| Mar 31, 2017 | -24.12% |
| Dec 31, 2016 | 23.31% |
| Sep 30, 2016 | -6.05% |
| Jun 30, 2016 | -18.06% |
| Mar 31, 2016 | -12.71% |
| Dec 31, 2015 | 123.00% |
| Sep 30, 2015 | -20.79% |
| Jun 30, 2015 | -9.84% |
| Mar 31, 2015 | -12.43% |
| Mar 31, 2014 | -10.08% |
| Dec 31, 2013 | -5.47% |
| Sep 30, 2013 | 175.91% |
| Jun 30, 2013 | -20.88% |
| Mar 31, 2013 | -19.53% |
| Dec 31, 2012 | 3.62% |
| Sep 30, 2012 | -15.29% |
| Jun 30, 2012 | 29.99% |
| Mar 31, 2012 | 68.90% |
| Dec 31, 2011 | -21.88% |
| Sep 30, 2011 | -21.54% |
| Jun 30, 2011 | -12.29% |
| Mar 31, 2011 | 39.91% |
| Dec 31, 2010 | -19.15% |
| Sep 30, 2010 | -19.21% |